NEWS
FDA drug approval lifts biotech Neuren to $1b valuation
MELBOURNE: Biotech Neuren Pharmaceuticals surged to a $1 billion valuation yesterday after the ... read more
MELBOURNE: Biotech Neuren Pharmaceuticals surged to a $1 billion valuation yesterday after the ... read more